NICE Consults On Dexamethasone Intravitreal Implant For The Treatment Of Macular Oedema Secondary To Retinal Vein Occlusion
In preliminary recommendations published today (8 February) NICE is asking Allergan for more information on its product dexamethasone (Ozurdex) intravitreal implant, for the treatment of macular oedema secondary to retinal vein occlusion (RVO). The macula is the central part of the retina responsible for colour vision and perception of fine detail...